Claudio Ferranti

509 total citations
26 papers, 368 citations indexed

About

Claudio Ferranti is a scholar working on Pathology and Forensic Medicine, Cancer Research and Oncology. According to data from OpenAlex, Claudio Ferranti has authored 26 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 13 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Claudio Ferranti's work include Breast Lesions and Carcinomas (17 papers), Breast Cancer Treatment Studies (13 papers) and Digital Radiography and Breast Imaging (4 papers). Claudio Ferranti is often cited by papers focused on Breast Lesions and Carcinomas (17 papers), Breast Cancer Treatment Studies (13 papers) and Digital Radiography and Breast Imaging (4 papers). Claudio Ferranti collaborates with scholars based in Italy. Claudio Ferranti's co-authors include Gianfranco Scaperrotta, S Bergonzi, Luigi Mariani, Cláudia Costa, Guillermo Yoldi, Elia Biganzoli, Ferdinando Draghi, Lorenzo Preda, Biagio Paolini and Alberto G. Conti and has published in prestigious journals such as European Journal of Cancer, European Radiology and Journal of Vascular and Interventional Radiology.

In The Last Decade

Claudio Ferranti

26 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudio Ferranti Italy 9 185 157 131 107 65 26 368
Mona El‐Khoury Canada 8 183 1.0× 217 1.4× 130 1.0× 49 0.5× 50 0.8× 12 350
Aba Harcos Germany 12 240 1.3× 215 1.4× 154 1.2× 133 1.2× 56 0.9× 20 448
Erin Neuschler United States 10 202 1.1× 74 0.5× 90 0.7× 223 2.1× 75 1.2× 15 445
Guita Rahbar United States 5 253 1.4× 216 1.4× 160 1.2× 84 0.8× 53 0.8× 7 494
U. Krainick‐Strobel Germany 10 117 0.6× 153 1.0× 170 1.3× 56 0.5× 80 1.2× 19 332
Gianfranco Scaperrotta Italy 12 210 1.1× 155 1.0× 232 1.8× 115 1.1× 160 2.5× 53 533
Chae Yeon Lyou South Korea 8 305 1.6× 137 0.9× 96 0.7× 189 1.8× 26 0.4× 14 428
Pier Paolo Campanino Italy 12 218 1.2× 167 1.1× 157 1.2× 47 0.4× 51 0.8× 18 432
S Bergonzi Italy 7 169 0.9× 93 0.6× 71 0.5× 100 0.9× 50 0.8× 18 272
Volker Duda Germany 11 185 1.0× 260 1.7× 170 1.3× 79 0.7× 107 1.6× 41 525

Countries citing papers authored by Claudio Ferranti

Since Specialization
Citations

This map shows the geographic impact of Claudio Ferranti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Ferranti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Ferranti more than expected).

Fields of papers citing papers by Claudio Ferranti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Ferranti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Ferranti. The network helps show where Claudio Ferranti may publish in the future.

Co-authorship network of co-authors of Claudio Ferranti

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Ferranti. A scholar is included among the top collaborators of Claudio Ferranti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Ferranti. Claudio Ferranti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pepa, Gianmarco Della, et al.. (2024). Assessing the malignancy of suspicious breast microcalcifications: the role of contrast enhanced mammography. La radiologia medica. 129(6). 855–863. 5 indexed citations
2.
Pepa, Gianmarco Della, Claudio Ferranti, Ilaria Maugeri, et al.. (2023). Magnetic Localization of Breast Lesions: A Large-Scale European Evaluation in a National Cancer Institute. Clinical Breast Cancer. 23(8). e491–e498. 8 indexed citations
3.
Scaperrotta, Gianfranco, et al.. (2021). Guiding vacuum-assisted biopsy in prone position: digital breast tomosynthesis vs stereotactic. Tumori Journal. 108(4). 326–330. 4 indexed citations
4.
Cosimo, Serena Di, et al.. (2020). Automated breast ultrasound compared to hand-held ultrasound in surveillance after breast-conserving surgery. Tumori Journal. 107(2). 132–138. 5 indexed citations
5.
Vingiani, Andrea, et al.. (2020). Contrast-enhanced mammography in the evaluation of breast calcifications: preliminary experience. Tumori Journal. 106(6). 491–496. 14 indexed citations
6.
Martelli, Gabriele, Rosalba Miceli, Secondo Folli, et al.. (2017). Sentinel node biopsy after primary chemotherapy in cT2 N0/1 breast cancer patients: Long-term results of a retrospective study. European Journal of Surgical Oncology. 43(11). 2012–2020. 19 indexed citations
7.
Ferranti, Claudio, Claudia Cavatorta, Chiara Maura Ciniselli, et al.. (2017). How Does the Display Luminance Level Affect Detectability of Breast Microcalcifications and Spiculated Lesions in Digital Breast Tomosynthesis (DBT) Images?. Academic Radiology. 24(7). 795–801. 2 indexed citations
8.
Scaperrotta, Gianfranco, et al.. (2015). Breast Foreign Body Extraction Using the Breast Lesion Excision System. Journal of Vascular and Interventional Radiology. 26(8). 1183–1183. 2 indexed citations
9.
Scaperrotta, Gianfranco, et al.. (2015). Performance and role of the breast lesion excision system (BLES) in small clusters of suspicious microcalcifications. European Journal of Radiology. 85(1). 143–149. 14 indexed citations
10.
Draghi, Ferdinando, et al.. (2012). Has color Doppler a role in the evaluation of mammary lesions?. Journal of Ultrasound. 15(2). 93–98. 16 indexed citations
11.
Trecate, Giovanna, Roberto Agresti, Daniele Vergnaghi, et al.. (2012). What is specific in hereditary breast cancer? High T2 signal intensity as a new semeiotic pattern?. European Journal of Radiology. 81. S165–S170. 1 indexed citations
12.
Ferranti, Claudio, et al.. (2011). Benign breast lesions: Ultrasound. Journal of Ultrasound. 14(2). 55–65. 40 indexed citations
13.
Scaperrotta, Gianfranco, et al.. (2008). Role of sonoelastography in non-palpable breast lesions. European Radiology. 18(11). 2381–2389. 126 indexed citations
14.
Trecate, Giovanna, Daniele Vergnaghi, Siranoush Manoukian, et al.. (2006). MRI in the Early Detection of Breast Cancer in Women with High Genetic Risk. Tumori Journal. 92(6). 517–523. 33 indexed citations
15.
Ferranti, Claudio, Guillermo Yoldi, Elia Biganzoli, et al.. (2000). Relationships between age, mammographic features and pathological tumour characteristics in non-palpable breast cancer.. British Journal of Radiology. 73(871). 698–705. 42 indexed citations
16.
Zambetti, Milvia, Monica Terenziani, Cesare Bartoli, et al.. (1996). Intermediate Doses of Cyclophosphamide Alone or Following Adriamycin in Advanced Breast Cancer. American Journal of Clinical Oncology. 19(1). 82–86. 3 indexed citations
17.
Sacchini, Virgilio, Alberto Luini, Roberto Agresti, et al.. (1993). Non palpable breast lesions: Analysis of 952 operated cases. European Journal of Cancer. 29. S66–S66. 1 indexed citations
18.
Cassano, Enrico, Guillermo Yoldi, Claudio Ferranti, et al.. (1993). Mammographic patterns in breast cancer chemoprevention with fenretinide (4-HPR). European Journal of Cancer. 29(15). 2161–2163. 8 indexed citations
19.
Yoldi, Guillermo, G Viganotti, S Bergonzi, et al.. (1993). [Microcalcifications in non-palpable breast carcinoma. Analysis of 427 cases].. PubMed. 85(5). 611–4. 2 indexed citations
20.
Ferranti, Claudio, et al.. (1992). [Microcalcifications in the diagnosis and follow-up after the primary chemotherapy of breast neoplasms].. PubMed. 84(1-2). 26–31. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026